Table 2.
Microbe | Route of infection | Target cell/site and localization | Innate immune effector molecules required for resistance | Impact of CCR2 deficiency |
---|---|---|---|---|
Bacteria | ||||
L. monocytogenes | Gastrointestinal | Intestinal epithelium, hepatic and splenic macrophages, hepatocytes (intracellular, cytoplasmic) | TNF, IFN-γ, RNI, ROI | ↑ susceptibilitya |
M. tuberculosis | Inhalation | Macrophages (intracellular, vacuolar) | TNF, IFN-γ, IL-12, RNI | ↑ susceptibility (high-dose iv infection)a |
S. typhimurium | Gastrointestinal | Intestinal epithelium, macrophages (intracellular, vacuolar) | TNF, IFN-γ, IL-12, ROI, RNI | Not determined |
Protozoa | ||||
T. gondii | Gastrointestinal | Macrophages and many nucleated cells (intracellular, vacuolar) | TNF, IFN-γ, IL-12 | ↑ susceptibilitya |
Fungi | ||||
A. fumigatus | Inhalation | Alveolar macrophages (intracellular conidia) | ROI | ↑ pulmonary allergic responses |
Alveolar spaces and lung tissue (extracellular conidia and hyphae) | ↓ fungal clearanceb |
monocytes implicated.
role of monocytes not known.